GlassScriptPhysician profile
Joseph Ad Brooks
NPI 1083642813
$2,025.93
in general payments reported to CMS, 2019-2025
22 companies · $55.04 in 2025
The $55.04 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $519 · 2021: $203 · 2022: $273 · 2023: $333 · 2024: $135 · 2025: $55.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.95 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $388.15 | 2019-2021 | |
| Abbvie INC. | $319.92 | 2019-2025 | |
| Astellas Pharma US INC | $193.46 | 2023-2024 | Veozah, Myrbetriq |
| Millicent US INC | $173.08 | 2020-2023 | Femring, Intrarosa |
| Duchesnay USA Incorporated | $153.79 | 2019 | |
| Pfizer INC. | $122.31 | 2019-2022 | |
| Ascend Therapeutics US, LLC | $120.86 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $79.39 | 2022-2023 | Vivjoa |
| Allergan, INC. | $77.75 | 2019-2020 | |
| Exeltis, USA INC. | $53.19 | 2020-2023 | Solosec |
| Scynexis, INC. | $50.30 | 2022 | |
| Arcutis Biotherapeutics, INC. | $48.73 | 2023 | |
| Mayne Pharma Commercial LLC | $48.52 | 2023 | |
| Exact Sciences Corporation | $34.73 | 2025 | |
| Avion Pharmaceuticals | $29.34 | 2021-2023 | Balcoltra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $28.16 | 2023 | Venaseal |
| Bayer Healthcare Pharmaceuticals INC. | $27.10 | 2019-2020 | |
| Zyla Life Sciences, INC. | $18.24 | 2020 | |
| Amag Pharmaceuticals, INC. | $17.02 | 2019 | |
| Minerva Surgical, INC | $15.86 | 2023 | |
| Lupin INC. | $13.33 | 2019 | |
| Medline Industries LP | $12.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.